Brussels: European Union negotiators struck a provisional deal on 23 June 2026 to tighten workplace limits on cancer-causing chemicals, agreeing the sixth revision of the bloc’s Carcinogens, Mutagens and Reprotoxic substances Directive in talks between the European Parliament and the Council. The Commission said the updated rules would set binding exposure limits for several high-risk substances and, once in force, help avert thousands of cases of occupational cancer across the EU.
How the rules target cancer-causing chemicals
The revision introduces or tightens occupational exposure limits for substances found in manufacturing, construction and heavy industry, including cobalt and inorganic cobalt compounds, polycyclic aromatic hydrocarbons (PAHs), 1,4-dioxane and isoprene. For the first time, the directive’s Annex I will list a substance, welding fumes, flagged for potentially reprotoxic effects, prompting updated definitions of “carcinogen”, “mutagen” and “reprotoxic substance”.
- A new exposure limit for isoprene is added to the directive’s scope.
- The transition period for the new PAH limit is extended to seven years and widened to cover all carbon and graphite manufacturers.
- Workers wearing personal protective equipment gain a right to regular breaks.
The health and economic case
The Commission estimates the strengthened directive could prevent around 1,700 cases of lung cancer and 19,000 work-related illnesses over the next 40 years, generating up to €1.16 billion in healthcare savings across the Union.
Trade unions welcomed the outcome. The European Trade Union Confederation said the agreement would extend protections against cancer-causing chemicals to around one million workers, while urging swift transposition into national law.
Reaction
The Commission “welcomes the provisional agreement reached by the European Parliament and the Council on the sixth revision of the Carcinogens, Mutagens and Reprotoxic substances Directive.”
Officials stressed that work-related cancer remains the leading cause of work-related deaths in the EU, and that updating exposure limits in line with scientific evidence is central to the bloc’s wider goal of cutting occupational disease. Employers’ groups have generally accepted the science-based limits but pressed for realistic transition periods, reflected in the seven-year window for PAHs.
Background
The Carcinogens, Mutagens and Reprotoxic substances Directive is the EU’s main legal shield against hazardous substances at work, and has been revised repeatedly since 2017 to add or tighten limits as toxicological evidence evolves. The Council agreed its negotiating position in December 2025, paving the way for the trilogue that concluded this week.
The provisional text must still be formally adopted by the Parliament and the Council before member states translate it into national law within an agreed deadline. For the carbon, cobalt and welding sectors most affected, the coming months will bring new monitoring duties, while for the workers exposed daily to cancer-causing chemicals, the revision promises lower long-term risk. The deal forms part of a broader EU push to cut work-related cancers and improve occupational safety standards by the end of the decade.




